Pathogenetic potential of antiphospholipid antibodies.
D000743:Anemia, Hemolytic / Q000276:immunology; D001696:Biomechanical Phenomena; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000276:immunology; D006801:Humans; D007132:Immunoglobulin Isotypes / Q000276:immunology*; D016682:Lupus Coagulation Inhibitor; D008180:Lupus Erythematosus, Systemic / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D010743:Phospholipids / Q000276:immunology*; D013921:Thrombocytopenia / Q000209:etiology* / Q000276:immunology; D014652:Vascular Diseases / Q000209:etiology* / Q000276:immunology
D001779:Blood Coagulation Factors; D007132:Immunoglobulin Isotypes; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids